Literature DB >> 27418054

[Coxibs].

W W Bolten1, K Krüger2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27418054     DOI: 10.1007/s00393-016-0148-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  12 in total

1.  Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

Authors:  F Catella-Lawson; M P Reilly; S C Kapoor; A J Cucchiara; S DeMarco; B Tournier; S N Vyas; G A FitzGerald
Journal:  N Engl J Med       Date:  2001-12-20       Impact factor: 91.245

2.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

Review 3.  Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy.

Authors:  J A Mitchell; T D Warner
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.

Authors:  Denis Poddubnyy; Martin Rudwaleit; Hildrun Haibel; Joachim Listing; Elisabeth Märker-Hermann; Henning Zeidler; Jürgen Braun; Joachim Sieper
Journal:  Ann Rheum Dis       Date:  2012-03-29       Impact factor: 19.103

5.  Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study.

Authors:  Jesper Lindhardsen; Gunnar Hilmar Gislason; Søren Jacobsen; Ole Ahlehoff; Anne-Marie Schjerning Olsen; Ole Rintek Madsen; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  Ann Rheum Dis       Date:  2013-06-08       Impact factor: 19.103

6.  Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.

Authors:  F E Silverstein; D Y Graham; J R Senior; H W Davies; B J Struthers; R M Bittman; G S Geis
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

7.  Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.

Authors:  Willy Gomm; Klaus von Holt; Friederike Thomé; Karl Broich; Wolfgang Maier; Anne Fink; Gabriele Doblhammer; Britta Haenisch
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 8.  [DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain].

Authors:  W W Bolten; K Krüger; S Reiter-Niesert; D O Stichtenoth
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

Review 9.  A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity.

Authors:  Philip G Conaghan
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

10.  Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

Authors:  N Bhala; J Emberson; A Merhi; S Abramson; N Arber; J A Baron; C Bombardier; C Cannon; M E Farkouh; G A FitzGerald; P Goss; H Halls; E Hawk; C Hawkey; C Hennekens; M Hochberg; L E Holland; P M Kearney; L Laine; A Lanas; P Lance; A Laupacis; J Oates; C Patrono; T J Schnitzer; S Solomon; P Tugwell; K Wilson; J Wittes; C Baigent
Journal:  Lancet       Date:  2013-05-30       Impact factor: 79.321

View more
  2 in total

1.  [Prescription of analgesics in patients with rheumatic diseases in Germany : A claims data analysis. German version].

Authors:  K Albrecht; U Marschall; J Callhoff
Journal:  Z Rheumatol       Date:  2021-02-26       Impact factor: 1.372

2.  Prescription of analgesics in patients with rheumatic diseases in Germany : A claims data analysis.

Authors:  K Albrecht; U Marschall; J Callhoff
Journal:  Z Rheumatol       Date:  2021-04-07       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.